5 results about "High triglycerides" patented technology

Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as non- alcoholic fatty liver disease (NAFLD), is a condition characterized by the accumulation of fat in the liver of individuals with no alcohol consumption, and at least one cardiometabolic risk factor (overweight / obesity, high blood pressure, high blood sugar, high triglycerides levels, low HDL-C levels). The inventors demonstrated that Rab30 silencing improve metabolic dysfunction–associated steatotic liver disease (MASLD). The present invention relates to a method for the treatment of metabolic dysfunction–associated steatotic liver disease (MASLD) in a subject in need thereof comprising the administration of a therapeutically effective amount of an inhibitor of Rab30.

The application discloses a biomarker for diagnosing acute pancreatitis and application thereof, and the biomarker is CTRC. The application also discloses a CTRC combined marker lipase for diagnosing acute pancreatitis, especially high triglyceride acute pancreatitis.

A topical composition comprising a nanonised L-glutathione and cyclodextrin complex, together with ascorbic acid in a weight ratio of glutathione to ascorbic acid from 7:1 to 15:1 and from 1:1 to 1:15 and a further compound comprising dexpanthenol, thiamine, benzalkonium chloride, sodium hyaluronate or acetyl-L-cysteine, which composition is topically administered for treating the symptoms of viral infection including COVID-19 and influenza, and for treating herpes simplex, herpes zoster, post herpetic neuralgia, genital herpes, alcohol detoxification, high triglycerides, age or liver spots and lupus.

The invention discloses a traditional Chinese medicine composition for treating mild and moderate hypertriglyceridemia, and belongs to the technical field of prevention and treatment of hypertriglyceridemia. The traditional Chinese medicine composition consists of the following components in parts by weight: 6-15 parts of broadleaf holly leaf, 3-10 parts of rhizoma acori graminei, 3-10 parts of turmeric, 6-15 parts of hawthorn and 3-10 parts of lotus leaf. The traditional Chinese medicine composition can effectively reduce the high triglyceride level of serum of a patient, helps the serum to recover to a normal value, also has a very good regulation and control effect on other blood fat indexes, can also improve intestinal flora ecology, alleviate the fatty liver degree of the patient, and helps the patient to recover to a health level in multiple dimensions. The traditional Chinese medicine composition has a very good treatment effect on light and medium hypertriglyceridemia patients who do not reach the western medicine medication standard, is simple in components, is prepared from medicinal and edible materials, has no side effect, and is suitable for long-term administration.

The invention discloses a traditional Chinese medicine composition for treating a high triglyceride phlegm-damp and turbid obstruction syndrome. Comprising the following raw material medicines in parts by weight: 18-25 parts of rhizoma alismatis, 14-20 parts of polygonum cuspidatum, 10-15 parts of lotus leaves, 10-15 parts of radix bupleuri, 14-20 parts of radix paeoniae alba, 14-20 parts of rhizoma atractylodis macrocephalae (fried), 14-20 parts of poria cocos, 14-20 parts of rhizoma coptidis (processed with ginger), 14-20 parts of gynostemma pentaphylla, 10-15 parts of herba epimedii, 30-40 parts of astragalus membranaceus, 21-30 parts of hawthorn, 14-20 parts of radix salviae miltiorrhizae (processed with wine), 2-4 parts of pseudo-ginseng (powder), 14-20 parts of oriental wormwood, 7-9 parts of fructus amomi, 10-15 parts of semen cassiae (fried), 4-6 parts of dried ginger and 3-5 parts of cinnamon. The traditional Chinese medicine composition disclosed by the invention is researched and developed on the basis of the etiology and pathogenesis of the high triglyceride phlegm-damp and turbid obstruction syndrome in traditional Chinese medicine diagnosis and treatment, and has an expected effect on treating the high triglyceride phlegm-damp and turbid obstruction syndrome.